Zhejiang Yatai Pharmaceutical Co., Ltd.
SZSE:002370.SZ
4.69 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 420.644 | 373.44 | 315.134 | 514.885 | 709.291 | 1,132.393 | 906.869 | 762.342 | 463.146 | 375.602 | 313.637 | 316.045 | 420.339 | 435.224 | 429.667 | 415.432 | 342.669 | 275.802 |
Cost of Revenue
| 285.646 | 239.835 | 195.758 | 251.295 | 455.362 | 626.3 | 498.594 | 458.376 | 272.792 | 231.618 | 216.628 | 247.771 | 290.116 | 307.757 | 300.751 | 301.79 | 249.923 | 207.333 |
Gross Profit
| 134.998 | 133.606 | 119.376 | 263.591 | 253.929 | 506.093 | 408.275 | 303.966 | 190.354 | 143.984 | 97.009 | 68.274 | 130.223 | 127.467 | 128.917 | 113.641 | 92.745 | 68.469 |
Gross Profit Ratio
| 0.321 | 0.358 | 0.379 | 0.512 | 0.358 | 0.447 | 0.45 | 0.399 | 0.411 | 0.383 | 0.309 | 0.216 | 0.31 | 0.293 | 0.3 | 0.274 | 0.271 | 0.248 |
Reseach & Development Expenses
| 21.795 | 26.138 | 28.618 | 37.349 | 70.099 | 57.205 | 87.102 | 53.993 | 22.834 | 15.911 | 17.503 | 18.681 | 14.447 | 14.926 | 0 | 8.517 | 3.049 | 2.645 |
General & Administrative Expenses
| 17.272 | 10.437 | 14.135 | 14.212 | 23.148 | 19.418 | -25.634 | -12.242 | 12.086 | 7.197 | 6.16 | 5.944 | 7.667 | 12.849 | 31.389 | 7.418 | 7.948 | 7.546 |
Selling & Marketing Expenses
| 76.613 | 72.429 | 140.876 | 205.433 | 197.55 | 156.806 | 128.082 | 66.417 | 58.264 | 45.532 | 44.765 | 51.234 | 45.649 | 30.249 | 30.578 | 27.436 | 20.765 | 17.117 |
SG&A
| 93.885 | 82.867 | 155.011 | 219.645 | 220.699 | 176.224 | 102.448 | 54.174 | 70.35 | 52.729 | 50.925 | 57.177 | 53.316 | 43.098 | 61.967 | 34.853 | 28.713 | 24.663 |
Other Expenses
| 51.89 | 33.765 | 58.723 | 65.212 | 83.689 | 0.028 | -0.005 | 8.65 | 3.151 | 2.778 | -0.015 | -2.691 | 5.426 | 0.301 | -0.048 | 2.471 | -0.197 | 0.112 |
Operating Expenses
| 161.037 | 142.77 | 242.352 | 322.206 | 374.487 | 307.881 | 245.158 | 168.08 | 127.507 | 97.422 | 92.437 | 98.686 | 87.65 | 77.53 | 64.099 | 58.2 | 42.191 | 35.328 |
Operating Income
| -63.453 | -16.171 | -122.975 | -58.616 | -120.558 | 174.528 | 163.45 | 101.725 | 62.969 | 45.618 | 5.815 | -28.639 | 45.077 | 47.988 | 57.082 | 46.139 | 50.301 | 27.342 |
Operating Income Ratio
| -0.151 | -0.043 | -0.39 | -0.114 | -0.17 | 0.154 | 0.18 | 0.133 | 0.136 | 0.121 | 0.019 | -0.091 | 0.107 | 0.11 | 0.133 | 0.111 | 0.147 | 0.099 |
Total Other Income Expenses Net
| 51.89 | -119.147 | -101.187 | 87.014 | -1,801.007 | -23.656 | 0.329 | -25.511 | 3.139 | 1.825 | 1.227 | -0.919 | 7.87 | -1.649 | -7.783 | -6.831 | -0.489 | -5.687 |
Income Before Tax
| -11.564 | -135.318 | -224.163 | 28.398 | -1,921.565 | 174.556 | 163.445 | 110.375 | 65.986 | 48.388 | 5.799 | -31.331 | 50.442 | 48.288 | 57.034 | 48.61 | 50.065 | 27.454 |
Income Before Tax Ratio
| -0.027 | -0.362 | -0.711 | 0.055 | -2.709 | 0.154 | 0.18 | 0.145 | 0.142 | 0.129 | 0.018 | -0.099 | 0.12 | 0.111 | 0.133 | 0.117 | 0.146 | 0.1 |
Income Tax Expense
| 0.313 | -2.597 | 4.118 | 1.123 | -0.312 | 22.023 | 23.054 | 11.594 | 9.497 | 7.82 | 0.319 | -5.613 | 6.647 | 6.242 | 8.882 | 7 | 10.978 | 5.997 |
Net Income
| -11.877 | -132.72 | -228.28 | 27.275 | -1,921.253 | 150.946 | 139.5 | 96.801 | 55.499 | 40.568 | 5.48 | -25.718 | 43.795 | 42.046 | 48.152 | 41.61 | 39.087 | 21.457 |
Net Income Ratio
| -0.028 | -0.355 | -0.724 | 0.053 | -2.709 | 0.133 | 0.154 | 0.127 | 0.12 | 0.108 | 0.017 | -0.081 | 0.104 | 0.097 | 0.112 | 0.1 | 0.114 | 0.078 |
EPS
| -0.02 | -0.25 | -0.43 | 0.051 | -3.58 | 0.28 | 0.26 | 0.22 | 0.14 | 0.1 | 0.015 | -0.065 | 0.11 | 0.11 | 0.16 | 0.14 | 0.13 | 0.071 |
EPS Diluted
| -0.02 | -0.25 | -0.43 | 0.051 | -3.58 | 0.28 | 0.26 | 0.22 | 0.14 | 0.1 | 0.015 | -0.065 | 0.11 | 0.11 | 0.16 | 0.14 | 0.13 | 0.071 |
EBITDA
| 80.618 | 25.443 | -88.062 | -19.692 | -1,188.227 | 245.675 | 207.9 | 187.565 | 100.433 | 78.181 | 33.603 | -5.214 | 72.904 | 70.475 | 79.907 | 68.802 | 57.055 | 31.759 |
EBITDA Ratio
| 0.192 | 0.068 | -0.279 | -0.038 | -1.675 | 0.217 | 0.229 | 0.246 | 0.217 | 0.208 | 0.107 | -0.016 | 0.173 | 0.162 | 0.186 | 0.166 | 0.167 | 0.115 |